Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Load latest

Lasa Supergenerics Ltd.

08 Nov 2022

17.64

5.06%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Board Meeting Intimation For Meeting Scheduled …

BSE India

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve and take on record Un-audited financial results along with limited review report for the quarter and half year ended September 30, 2022 and / or to discuss and any other business / matter with the permission of chair.

pdf

Lasa Supergenerics Ltd.

18 Oct 2022

17.64

5.06%

Company Update

Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended September 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita ShettyDesignation :- Company Secretary and Compliance Officer

Lasa Supergenerics Ltd.

18 Oct 2022

17.64

5.06%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company.

pdf

Lasa Supergenerics Ltd.

30 Sep 2022

17.64

5.06%

SAST

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

BSE India

This is to inform you that as per the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. October 01, 2022 till 48 hours after the declaration of unaudited financial results (both days inclusive) for the quarter & half year ended on September 30, 2022.

pdf

Lasa Supergenerics Ltd.

28 Sep 2022

17.64

5.06%

AGM

Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

In terms of the subject referred, the details regarding consolidated voting results of the business transacted at the 7th Annual General Meeting (AGM) of the Company held on Monday, 26th September, 2022 is annexed herewith for your reference and records. The Company had appointed M/s Amit R. Dadheech & Associates as the Scrutinizer for remote e-Voting and e-Voting conducted at the AGM. As per the Scrutinizer's Report, all the Resolutions as set out in the Notice of 7th AGM have been duly approved by the Members with requisite majority.

pdf

Lasa Supergenerics Ltd.

26 Sep 2022

17.64

5.06%

AGM

Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015, as amended, we are submitting herewith the summary of proceedings of the 7th Annual General Meeting of the Company held on Monday, 26th September, 2022 at 09:30 a.m. Indian Standard Time ('IST'), which concluded at 10:15 am (including time allowed for e-voting at the AGM) through Video Conferencing/ Other Audio Visual Means ('VC/OAVM'). The Meeting was held in compliance with the General Circulars issued by the Ministry of Corporate Affairs (MCA) and Circular issued by the Securities and Exchange Board of India (SEBI) and as per the applicable provisions of the Companies Act, 2013 and the Rules made thereunder.

pdf

Lasa Supergenerics Ltd.

02 Sep 2022

17.64

5.06%

Corp. Note

Lasa Supergenerics Ltd - 540702 - Reg. 34 (1) Annual Report.

BSE India

Annual Report for the financial year ended March 31, 2022 along with Notice of the Seventh (7th ) Annual General Meeting and Cut-off Date for the purpose of E voting and Dividend.

pdf

Lasa Supergenerics Ltd.

29 Aug 2022

17.64

5.06%

Corp. Action

Lasa Supergenerics Ltd - 540702 - Compliance Of Regulation 42 Of SEBI (Listing Obligations And Disclosure …

BSE India

The Record Date for determining the members eligible to receive the aforesaid dividend will be 19 September 2022. The Dividend will be paid to those Shareholders whose name appears on the Register of Members as on 19th September 2022 in respect of the shares held in the physical form. In respect of shares held in dematerialized form dividend will be paid on the basis of beneficial ownership as per the details provided by the Depositories for this purpose as at the end of the business hours on 19th September 2022.

pdf

Lasa Supergenerics Ltd.

26 Aug 2022

17.64

5.06%

Corp. Note

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligation and Discourse Requirement) Regulation 2015 we would like to inform you that the Board of Directors at their meeting held today which commenced at 01:00 p.m. and concluded at 03:30 p.m. have considered and approved the following: 1) The Notice of the Seventh (7th) Annual general Meeting (AGM) of the Company. 2) The 7th AGM is scheduled to be held on Monday, September 26, 2022 at 9.30 a.m. through Video conferencing (VC) / Other Audio-Visual means (OAVM).

pdf

Lasa Supergenerics Ltd.

08 Aug 2022

17.64

5.06%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

considered and approved the following: 1. The statement of unaudited Financial Results of the Company for the Quarter Ended on June 30, 2022. 2. Limited Review Report from Statutory Auditor for the quarter ended on June 30, 2022. 3. Re appointment of Ms. Manali Bhagtani (DIN: 08067867) as an Independent Director of the Company for the second term of 5 years. The brief profile of the Independent Director is enclosed as Annexure-I.

pdf

Is Lasa Supergenerics Ltd. worth buying?

50 Votes:

Buy 76.0%

Sell 18.0%

Hold 6.0%